Family Medicine and Clinical Epidemiology
1 – 10 of 945
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Economic evaluation of mindfulness group therapy for patients with depression, anxiety, stress and adjustment disorders compared with treatment as usual
Saha, Sanjib LU ; Jarl, Johan LU
;
Gerdtham, Ulf-G
LU
;
Sundquist, Kristina
LU
and
Sundquist, Jan
LU
(2020)
In British Journal of Psychiatry
216(4).
p.197-203
Mark
- Epilepsy in second-generation immigrants : a cohort study of all children up to 18 years of age in Sweden
-
Second primary cancers in non-Hodgkin lymphoma : Family history and survival
Chattopadhyay, Subhayan LU
;
Zheng, Guoqiao
LU
;
Sud, Amit
LU
;
Sundquist, Kristina
LU
;
Sundquist, Jan
LU
;
Försti, Asta
LU
;
Houlston, Richard
;
Hemminki, Akseli
and
Hemminki, Kari
LU
(2020)
In International Journal of Cancer
146(4).
p.970-976
Mark
- Risk of hypertension into adulthood in persons born prematurely : A national cohort study
-
Poor academic performance in offspring of survivors with childhood or adolescent central nervous system tumor in Sweden
Huang, Wuqing LU
;
Sundquist, Kristina
LU
;
Sundquist, Jan
LU
and
Ji, Jianguang
LU
(2020)
In International Journal of Cancer
Mark
- The rearing environment and the risk for alcohol use disorder : A Swedish national high-risk home-reared v. adopted co-sibling control study
- Socioeconomic sequelae of drug abuse in a Swedish national cohort
- Urolithiasis in second-generation immigrant children younger than 18 years of age in Sweden
- Lower cardiovascular stress during resistance training performed with inter-repetition rests in elderly coronary patients
-
Association between tumor characteristics and second primary cancers with cutaneous melanoma survival : A nationwide cohort study
Zheng, Guoqiao LU ; Chattopadhyay, Subhayan LU
;
Sundquist, Kristina
LU
;
Sundquist, Jan
LU
;
Försti, Asta
LU
;
Hemminki, Akseli
and
Hemminki, Kari
LU
(2020)
In Pigment Cell and Melanoma Research
Mark